News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,251 Results
Type
Article (86915)
Company Profile (704)
Press Release (765631)
Multimedia
Podcasts (149)
Webinars (19)
Section
Business (232834)
Career Advice (4133)
Deals (39764)
Drug Delivery (130)
Drug Development (91120)
Employer Resources (199)
FDA (18197)
Job Trends (17367)
News (396884)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (33)
Allergies (109)
Alliances (56975)
ALS (120)
Alzheimer's disease (1578)
Antibody-drug conjugate (ADC) (188)
Approvals (18144)
Artificial intelligence (403)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (102)
Brain cancer (41)
Breast cancer (394)
Cancer (3128)
Cardiovascular disease (251)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (579)
Cervical cancer (25)
Clinical research (74361)
Collaboration (1120)
Company closure (3)
Compensation (729)
Complete response letters (35)
COVID-19 (2908)
CRISPR (69)
C-suite (369)
Cystic fibrosis (123)
Data (3134)
Decentralized trials (2)
Denatured (53)
Depression (78)
Diabetes (381)
Diagnostics (6983)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (186)
Drug pricing (153)
Drug shortages (36)
Duchenne muscular dystrophy (144)
Earnings (97571)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131506)
Executive appointments (913)
FDA (19972)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1023)
Gene editing (150)
Generative AI (40)
Gene therapy (444)
GLP-1 (937)
Government (5269)
Grass and pollen (7)
Guidances (186)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (186)
Immuno-oncology (12)
Indications (41)
Infectious disease (3108)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (73)
Intellectual property (126)
Interviews (813)
IPO (17906)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (58)
Layoffs (595)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (437)
Lymphoma (218)
Machine learning (12)
Management (65)
Manufacturing (458)
MASH (101)
Medical device (14737)
Medtech (14743)
Mergers & acquisitions (22593)
Metabolic disorders (971)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (148)
Neuropsychiatric disorders (44)
Neuroscience (2344)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (123)
Pancreatic cancer (128)
Parkinson's disease (201)
Partnered (25)
Patents (324)
Patient recruitment (176)
Peanut (55)
People (65753)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22950)
Phase II (32286)
Phase III (24313)
Pipeline (1719)
Policy (246)
Postmarket research (3553)
Preclinical (10364)
Press Release (72)
Prostate cancer (153)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (532)
Real estate (7402)
Recruiting (76)
Regulatory (27215)
Reports (62)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (11)
RSV (60)
Schizophrenia (99)
Series A (174)
Series B (119)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (85)
Tariffs (68)
The Weekly (94)
Vaccines (924)
Venture capital (59)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (98)
Last 7 days (418)
Last 30 days (1971)
Last 365 days (33996)
2025 (18790)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50555)
Australia (8881)
California (7846)
Canada (2427)
China (731)
Colorado (340)
Connecticut (352)
Delaware (209)
Europe (115991)
Florida (1166)
Georgia (266)
Hawaii (2)
Idaho (66)
Illinois (748)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1111)
Massachusetts (6012)
Michigan (278)
Minnesota (492)
Mississippi (3)
Missouri (103)
Montana (32)
Nebraska (26)
Nevada (84)
New Hampshire (73)
New Jersey (2206)
New Mexico (31)
New York (2198)
North Carolina (1252)
North Dakota (10)
Northern California (3384)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1683)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2911)
Tennessee (130)
Texas (1205)
United States (29653)
Utah (231)
Virginia (216)
Washington D.C. (80)
Washington State (695)
West Virginia (4)
Wisconsin (86)
There are 853,251 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
With Potential Tariffs Weeks Away, AstraZeneca Makes $50B U.S. Manufacturing Push
The money will focus on a manufacturing plant in Virginia that will make the company’s weight management and metabolic drugs like the hypertension drug baxdrostat and oral GLP-1 therapies.
July 22, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Concentra Buys Beleaguered iTeos at Slight Discount
In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage performance of its anti-TIGIT antibody belrestotug.
July 22, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ECLIPSEBIO
Why Countries are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of Arcturus Therapeutics.
July 22, 2025
·
1 min read
·
Lori Ellis
Duchenne muscular dystrophy
Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys
After initially refusing to suspend Elevidys distribution after two deaths, Sarepta has now given in to the FDA’s request, noting the need to maintain a good working relationship with the regulator.
July 22, 2025
·
2 min read
·
Tristan Manalac
Funding
Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs
The company is pushing inhaled versions of common oral drugs with the hope of avoiding severe side effects.
July 22, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025
July 22, 2025
·
1 min read
Press Releases
Logical Biological Launches Sister Company, Logical Antigen, Delivering Customised Antigen and Protein Purification for IVD Market
July 22, 2025
·
5 min read
Press Releases
Danaher Reports Second Quarter 2025 Results
July 22, 2025
·
19 min read
Press Releases
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies
July 22, 2025
·
5 min read
Press Releases
Llusern Scientific Announces Key Appointments to Strengthen its Executive Team
July 22, 2025
·
5 min read
1 of 85,326
Next
